UNSPSC 51343104: Emivirine

This classification denotes a reverse transcriptase inhibitor with the molecular formula C17H22N2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier X87G8IX72O, chemically known as 2,4(1h,3h)-pyrimidinedione, 1-(ethoxymethyl)-5-(1-methylethyl)-6-(phenylmethyl)- but generally known as emivirine, which bears US NIH Compound Identifier 65013. European Medicines Agency schedules Emivirine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01880MIG.

UNSPSC 51343104 Emivirine is a Commodity code representing pharmaceutical products state and local governments procure for public health and emergency preparedness programs. The recent solicitation activity under this code shows state and local health agencies and counties purchasing pharmaceutical supplies through competitive bidding and cooperative purchasing vehicles, though the specific products tagged to this code vary — ranging from antibiotic and antimicrobial tablets to emergency medical supplies such as naloxone and drug deactivation systems. Issuing bodies include state health departments and county governments, often coordinating purchases through established procurement consortia to meet recurring inventory and emergency-response needs. These agencies typically structure purchases with fixed terms, renewal options, and quarterly or annual delivery schedules to support clinical, emergency, and community health operations.

Geographic activity appears concentrated in the Southeast and Midwest, with Illinois Department of Public Health and Seminole County, Florida representing recent award and solicitation activity. The Illinois Department of Public Health awarded a $2,999,999.11 piggyback contract through the MMCAP Infuse consortium to Chartwell Rx LLC on August 28, 2026, for the supply of Doxycycline Hyclate 100mg tablets and Ciprofloxacin Hydrochloride 500mg tablets under Invitation for Bid 26-482DPH-PREPD-B-53392, with a 12-month initial term and renewal options for years 2 and 3. Seminole County, Florida released an Invitation for Bid on June 30, 2026, seeking 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries to its Community Health Building in Sanford, due July 26, 2023. Both procurements include standard compliance requirements (drug-free workplace, E-Verify) and fixed-fee pricing structures, with no explicit set-aside designations noted in the recent awards.